April 6, 2022 Comments Off on New patent for Gilead Sciences drug VEKLURY Posted in: Patent Added Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent for Gilead Sciences drug VEKLURY appeared first on DrugPaten…
April 6, 2022 Comments Off on New patent for Genentech Inc drug XOFLUZA Posted in: Patent Added Annual Drug Patent Expirations for XOFLUZA Xofluza is a drug marketed by Genentech Inc and is included in two NDAs. It is available from two suppliers. There are six patents…
The post New patent for Genentech Inc drug XOFLUZA appeared first on DrugPate…